SCHEMBL29792984

SCHEMBL29792984

COC1C2O[Si](C(C)C)(C(C)C)O[Si](C(C)C)(C(C)C)OC[C@H]2O[C@H]1n1cnc2c(Cl)ncnc21

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 4/20 0.44
▸ PDE4D Q08499 4/20 0.44
▸ PDE4B Q07343 3/20 0.44
▸ PDE4C Q08493 3/20 0.44
▸ STING1 Q86WV6 6/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ TYMP P19971 1/20 0.34
▸ LMNA P02545 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ ADRB3 P13945 1/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ PDE3A Q14432 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1797958 1.00 PDE4A (0.44) PDE4APDE4DPDE4BPDE4CSTING1
SCHEMBL1798803 0.89 PDE4A (0.45) PDE4APDE4DPDE4BPDE4CSTING1
SCHEMBL1798801 0.89 PDE4A (0.45) PDE4APDE4DPDE4BPDE4CSTING1
SCHEMBL29792990 0.87 PDE4A (0.56) PDE4APDE4DPDE4BPDE4CSTING1
SCHEMBL17889822 0.87 PDE4A (0.56) PDE4APDE4DPDE4BPDE4CSTING1
SCHEMBL1801703 0.87 PDE4A (0.56) PDE4APDE4DPDE4BPDE4CSTING1
SCHEMBL16871701 0.87 PDE4A (0.56) PDE4APDE4DPDE4BPDE4CSTING1
SCHEMBL29792971 0.87 MEN1 (0.41) PDE4APDE4DPDE4BPDE4CADORA3
SCHEMBL3285873 0.85 PRMT5 (0.36) PDE4APDE4DPDE4BPDE4CMEN1
SCHEMBL17363566 0.83 P2RY12 (0.34) PDE4APDE4DPDE4BPDE4CSTING1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4277636-A1 MODIFIED OLIGONUCLEOTIDES Alnylam Pharmaceuticals, Inc. (US) 2023-11-22 — — EP disclosed
WO-2022155418-A1 MODIFIED OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2022-07-21 — — WO disclosed
Send feedback